CohBar Inc. appointed John Amatruda to the board.
Amatruda is a co-founder and scientific adviser to the company. He is also currently on the board of CureDM, Prosciento, and Fractyl.
CohBar is a biotechnology company focused on the research and development of mitochondria-based therapeutics for age-related diseases.